Syngene International Ltd (stock symbol: SYNGENE.NS) is a publicly traded company listed on NSE, operating within the PHARMA sector. As of the latest trading session, Syngene International Ltd is trading at ₹685.91 with a market capitalization of 136.00B. The stock has experienced a gain of 0.81% in today's trading, reflecting bullish sentiment among market participants.
The day's trading range has been between ₹672.40 (low) and ₹692.77 (high), with an opening price of ₹673.73 compared to the previous close of ₹680.40. Approximately 7.07M shares have changed hands, indicating strong liquidity and active investor interest in this stock.
Key Market Metrics for SYNGENE.NS:
Investors tracking SYNGENE.NS should note that the P/E ratio of 31.15 indicates moderate market expectations for future growth. Understanding these fundamental metrics alongside technical price action gives investors a comprehensive view of Syngene International Ltd's market position and future prospects on NSE.
The PHARMA sector has been an area of consistent interest for market participants. Companies within this sector demonstrate varying performance based on macroeconomic factors, regulatory changes, and company-specific developments. Syngene International Ltd continues to adapt to market dynamics while maintaining its competitive positioning.
For technical analysis, traders monitor several key levels for SYNGENE.NS: support at ₹672.40 and ₹680.40, and resistance at ₹692.77. The P/E ratio of 31.15 provides valuation context, helping investors determine if Syngene International Ltd is trading at a premium or discount relative to its earnings potential. Regular monitoring of quarterly results, management commentary, and sector-wide trends will help investors stay informed about SYNGENE.NS's trajectory on NSE.
The current live price of Syngene International Ltd (SYNGENE.NS) is ₹685.91 as of the most recent market data update on NSE. This price reflects the last traded value and changes in real-time during market hours. Today's trading session opened at ₹673.73, compared to the previous day's close of ₹680.40.
The intraday price action for SYNGENE.NS shows a high of ₹692.77 and a low of ₹672.40, giving the stock a daily trading range of approximately ₹20.37. The stock has experienced a gain of 0.81% in today's session. The total volume traded stands at approximately 7.07M shares.
Key Market Metrics for SYNGENE.NS:
Market participants tracking SYNGENE.NS should note that these prices are live and updated from market data providers. The market cap of 136.00B places Syngene International Ltd among significant companies listed on NSE. Trading volume of 7.07M shares suggests strong liquidity and active investor interest in this stock.
Understanding the price history of Syngene International Ltd (SYNGENE.NS) is essential for both technical and fundamental analysis. The stock's current price of ₹685.91 can be better understood in the context of its recent trading patterns and long-term trends on NSE.
Today's price action shows SYNGENE.NS opening at ₹673.73 compared to the previous close of ₹680.40. The intraday high of ₹692.77 and low of ₹672.40 represent the price boundaries for today's trading session. The positive movement of 0.81% provides insight into the day's market sentiment toward Syngene International Ltd.
For technical analysis, traders monitor several key levels for SYNGENE.NS:
The P/E ratio of 31.15 provides a valuation benchmark comparing Syngene International Ltd's stock price to its earnings per share. These fundamental metrics, combined with technical price action, give investors a comprehensive view of SYNGENE.NS's current market position and future prospects on NSE.
Investors are advised to use the interactive chart above to analyze SYNGENE.NS's price trends across different timeframes — from intraday 1D charts for short-term traders to 1Y charts for long-term investors. The combination of fundamental analysis and technical chart patterns helps in making well-informed decisions about Syngene International Ltd stock in the PHARMA sector.
Indian investors looking to purchase Syngene International Ltd (SYNGENE.NS) shares have several reliable options through registered stockbrokers and trading platforms. The process of buying SYNGENE.NS shares in India involves opening a demat and trading account with a SEBI-registered broker, completing the KYC (Know Your Customer) process, and funding the account to start trading. Below are the most popular platforms for investing in SYNGENE.NS and other stocks on NSE.
Zerodha is India's largest retail stockbroker by active clients and offers a seamless platform for buying SYNGENE.NS shares. With Zerodha's Kite platform, you can trade Syngene International Ltd stocks on NSE and BSE with zero brokerage on equity delivery trades. The account opening process is fully digital and can be completed in minutes. Open a Zerodha account here to start investing in SYNGENE.NS with zero brokerage on delivery trades and flat €20 per trade on intraday and F&O.
Groww offers an intuitive mobile-first investment platform that is perfect for beginners looking to buy Syngene International Ltd shares. With a simple interface and educational resources, Groww makes it easy to invest in SYNGENE.NS and thousands of other stocks and mutual funds. The platform offers zero account opening fees and zero brokerage on equity delivery. Sign up on Groww to begin your investment journey with Syngene International Ltd shares.
Angel One is another excellent choice for trading SYNGENE.NS stocks, offering advanced charting tools, research reports, and expert recommendations. The platform provides free equity delivery trades and a powerful mobile trading app. Angel One's research team publishes regular analysis on Syngene International Ltd and other PHARMA sector stocks to help you make informed decisions. Open an Angel One account and get access to expert stock recommendations and advanced trading tools.
Steps to Buy SYNGENE.NS Shares in India:
Disclaimer: Investments in the stock market are subject to market risks. Past performance does not guarantee future returns. Please consult a financial advisor before making investment decisions.
Here are other stocks in the PHARMA sector that investors tracking Syngene International Ltd (SYNGENE.NS) may also be interested in. These companies operate in similar business areas and their performance can provide context for sector-wide trends on NSE.
The current live price of Syngene International Ltd (SYNGENE.NS) is ₹ as traded on NSE. This price updates in real-time during market hours. Investors tracking SYNGENE.NS can use the interactive chart on this page to monitor price movements across different timeframes and make informed trading decisions.
Indian investors can buy SYNGENE.NS shares by opening a demat and trading account with any SEBI-registered stockbroker such as Zerodha, Groww, or Angel One. The process involves completing online KYC verification with your Aadhaar and PAN cards, funding your trading account, and placing a buy order for the desired quantity on the NSE exchange. We recommend comparing brokerage fees and platform features before choosing a broker.
Syngene International Ltd operates in the PHARMA sector and is listed on NSE. The company's stock performance is influenced by sector-specific trends, economic conditions, regulatory developments, and company-specific factors within the PHARMA industry. Investors should monitor sector performance alongside individual stock metrics for a comprehensive view.
The current market capitalization of Syngene International Ltd is approximately 136.00B, placing it in the mid-cap category on NSE. The P/E ratio stands at 31.15, which provides a valuation benchmark comparing the stock price to earnings per share. These metrics help investors assess whether SYNGENE.NS is fairly valued compared to peers in the PHARMA sector.
Whether SYNGENE.NS (Syngene International Ltd) is a good investment depends on your individual financial goals, risk tolerance, and investment horizon. The stock currently trades at ₹685.91 with a positive change of 0.81% today. The P/E ratio of 31.15 suggests moderate valuation. We recommend consulting a SEBI-registered financial advisor and using our interactive chart tools to conduct your own research before making investment decisions.